Xtl Biopharmaceuticals annual return on equity
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Xtl Biopharmaceuticals Return on Equity (ROE) Growth & History (XTLB)
Xtl Biopharmaceuticals's return on equity was −269.02% for fiscal 2025.
View full Xtl Biopharmaceuticals company overviewXtl Biopharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −269.02% | −242.19 pp |
| 2024 | 2024-12-31 | −26.83% | +30.48 pp |
| 2023 | 2023-12-31 | −57.31% | −28.42 pp |
| 2022 | 2022-12-31 | −28.89% | −38.62 pp |
| 2021 | 2021-12-31 | 9.73% | +68.07 pp |
| 2020 | 2020-12-31 | −58.34% | −47.27 pp |
| 2019 | 2019-12-31 | −11.07% | −77.72 pp |
| 2018 | 2018-12-31 | 66.65% | +91.42 pp |
| 2017 | 2017-12-31 | −24.77% | +42.43 pp |
| 2016 | 2016-12-31 | −67.20% | — |
Xtl Biopharmaceuticals quarterly return on equity
Q2.21
Q2.22
Q4.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −6.66% | — |
| Q2 2022 | 2022-06-30 | −5.23% | +28.13 pp |
| Q2 2021 | 2021-06-30 | −33.36% | — |
Xtl Biopharmaceuticals return on equity trends
Over the last five fiscal years, Xtl Biopharmaceuticals's return on equity decreased from −58.34% to −269.02%, a change of −210.68 percentage points. The latest reported quarter, Q4 2024, shows −6.66%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xtl Biopharmaceuticals source filings ↗